Risk to patients balanced against risk to labs as FDA moves on lab developed tests
from Clinical Informatics News
In the nearly 40 years that laboratory developed tests have enjoyed a policy of "enforcement discretion," they have grown from a small but vital niche used mainly by hospital labs to diagnose rare diseases, to an industry where big players like Myriad Genetics and Genomic Health can post profits in the hundreds of millions of dollars.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063